Article Details

Long COVID: Diabetes drug metformin may reduce risk by 64% - MedicalNewsToday

Retrieved on: 2025-09-18 22:42:32

Tags for this article:

Click the tags to see associated articles and topics

Long COVID: Diabetes drug metformin may reduce risk by 64% - MedicalNewsToday. View article details on hiswai:

Excerpt

Starting the diabetes drug metformin within 90 days of SARS-CoV-2 infection decreased the risk for developing long COVID by 64%, according to a ...

Article found on: www.medicalnewstoday.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo